Sixth Varda mission successfully returns
spacenews.com May 22, 2026

Sixth Varda mission successfully returns

AI-summarised brief · reviewed before publication

Varda Space Industries completed its sixth reentry mission, with the capsule landing at the Koonibba Test Range in South Australia. The mission was funded by the Air Force Research Laboratory to test hypersonic technology using commercial spacecraft. The capsule tested autonomous navigation and collected temperature data during reentry. Varda's spacecraft can be used for both defense and commercial missions, including microgravity research for pharmaceuticals. The company has partnered with United Therapeutics to study drug development in microgravity. Varda's vice president stated that every reentry builds on the last, providing valuable data for partners. The company aims to fly its first drug for United Therapeutics in 2027.

💡 Why It Matters

  • · Varda's ability to offer low-cost hypersonic testing disrupts traditional methods, making it an attractive option for the defense industry.
  • · By leveraging its spacecraft for both defense and pharmaceutical research, Varda can accelerate innovation in multiple fields.